Quarterly report pursuant to Section 13 or 15(d)

SUBSEQUENT EVENTS (Details Narrative)

v3.7.0.1
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended
Jul. 14, 2017
Jun. 19, 2017
May 30, 2017
Apr. 02, 2017
Jan. 02, 2017
Aug. 07, 2017
Jul. 31, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2016
Jun. 30, 2017
Jun. 30, 2016
 [1]
Number of option to purchase granted under the plan               10,000 23,000 102,000    
Capital contribution paid                     $ 120,000
2012 Omnibus Incentive Compensation Plan [Member]                        
Number of option to purchase granted under the plan     10,000   50,000              
Master Purchase and Option Agreement [Member] | Arcadian Telepsychiatry LLC & Mr. Mr. Robert Plotkin [Member]                        
Percentage of equity investment       10.00%                
Capital contribution paid   $ 20,000   $ 100,000                
Master Purchase and Option Agreement [Member] | Mr. Mr. Robert Plotkin [Member]                        
Number of shares issued       1,000                
Common Stock [Member]                        
Number of shares issued                     477,000  
Subsequent Event [Member] | Chairman Services Agreement [Member] | Mr. Robin L. Smith, M.D [Member]                        
Annual cash fee $ 300,000                      
Subsequent Event [Member] | Chairman Services Agreement [Member] | Mr. Robin L. Smith, M.D [Member] | Stock Option [Member]                        
Expiration period 10 years                      
Subsequent Event [Member] | Chairman Services Agreement [Member] | Mr. Robin L. Smith, M.D [Member] | 2012 Omnibus Incentive Compensation Plan [Member] | Restricted Stock [Member]                        
Number of shares granted under the plan 25,000                      
Subsequent Event [Member] | Chairman Services Agreement [Member] | Mr. Robin L. Smith, M.D [Member] | 2012 Omnibus Incentive Compensation Plan [Member] | Stock Option [Member]                        
Number of option to purchase granted under the plan 75,000                      
Number of option to purchase granted annual award limits 50,000                      
Description of vesting period

The 2017 Option Award will vest on December 1, 2018.

                      
Subsequent Event [Member] | Chairman Services Agreement [Member] | Mr. Robin L. Smith, M.D [Member] | Other Compensation Plan [Member] | Stock Option [Member]                        
Description of vesting period

All options granted under the Agreement will vest 1/3 on the date of grant, 1/3 on the six month anniversary of the date of grant and 1/3 on the twelve month anniversary of the date of grant.

                      
Subsequent Event [Member] | Master Purchase and Option Agreement [Member] | Arcadian Telepsychiatry LLC & Mr. Mr. Robert Plotkin [Member]                        
Capital contribution paid           $ 70,000            
Public Offering [Member] | Subsequent Event [Member]                        
Proceeds from public offering             $ 8,793,750          
Offering share price (in dollars per share)             $ 5.25          
Public Offering [Member] | Subsequent Event [Member] | Common Stock [Member]                        
Number of shares issued             1,675,000          
Public Offering [Member] | Subsequent Event [Member] | Warrant [Member]                        
Number of shares issued             1,675,000          
Number of each warrant called             1          
Warrant exercise price (in dollars per share)             $ 5.25          
Warrant term             5 years          
45-day Option Over-Allotment Option [Member] | Subsequent Event [Member]                        
Number of shares issued             251,250          
Common Stock and Warrants [Member] | Public Offering [Member] | Subsequent Event [Member]                        
Proceeds from public offering             $ 8,790,000          
[1] (As Revised)